NM_006073.4:c.1304C>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_006073.4(TRDN):c.1304C>A(p.Ala435Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A435V) has been classified as Uncertain significance.
Frequency
Consequence
NM_006073.4 missense
Scores
Clinical Significance
Conservation
Publications
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- catecholaminergic polymorphic ventricular tachycardia 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- familial long QT syndromeInheritance: AR Classification: STRONG Submitted by: G2P
- long QT syndromeInheritance: AR Classification: STRONG Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006073.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRDN | NM_006073.4 | MANE Select | c.1304C>A | p.Ala435Glu | missense | Exon 20 of 41 | NP_006064.2 | ||
| TRDN | NM_001251987.2 | c.1307C>A | p.Ala436Glu | missense | Exon 20 of 21 | NP_001238916.1 | |||
| TRDN | NM_001407315.1 | c.1247C>A | p.Ala416Glu | missense | Exon 19 of 20 | NP_001394244.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRDN | ENST00000334268.9 | TSL:1 MANE Select | c.1304C>A | p.Ala435Glu | missense | Exon 20 of 41 | ENSP00000333984.5 | ||
| TRDN | ENST00000662930.1 | c.1307C>A | p.Ala436Glu | missense | Exon 20 of 21 | ENSP00000499585.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151994Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000282 AC: 7AN: 248392 AF XY: 0.0000297 show subpopulations
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460150Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 726376 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151994Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74236 show subpopulations
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 435 of the TRDN protein (p.Ala435Glu). This variant is present in population databases (rs370712881, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 841543). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TRDN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Uncertain:1
The p.A435E variant (also known as c.1304C>A), located in coding exon 20 of the TRDN gene, results from a C to A substitution at nucleotide position 1304. The alanine at codon 435 is replaced by glutamic acid, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at